Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar;99(2):356-419.
doi: 10.1111/php.13730. Epub 2022 Nov 3.

The Photosensitizer Temoporfin (mTHPC) - Chemical, Pre-clinical and Clinical Developments in the Last Decade

Affiliations
Review

The Photosensitizer Temoporfin (mTHPC) - Chemical, Pre-clinical and Clinical Developments in the Last Decade

Arno Wiehe et al. Photochem Photobiol. 2023 Mar.

Abstract

This review follows the research, development and clinical applications of the photosensitizer 5,10,15,20-tetra(m-hydroxyphenyl)chlorin (mTHPC, temoporfin) in photodynamic (cancer) therapy (PDT) and other medical applications. Temoporfin is the active substance in the medicinal product Foscan® authorized in the EU for the palliative treatment of head and neck cancer. Chemistry, biochemistry and pharmacology, as well as clinical and other applications of temoporfin are addressed, including the extensive work that has been done on formulation development including liposomal formulations. The literature has been covered from 2009 to early 2022, thereby connecting it to the previous extensive review on this photosensitizer published in this journal [Senge, M. O. and J. C. Brandt (2011) Photochem. Photobiol. 87, 1240-1296] which followed its way from initial development to approval and clinical application.

PubMed Disclaimer

References

REFERENCES

    1. Raab, O. (1900) Über die Wirkung fluoreszierender Stoffe auf Infusorien. Z. Biol. 39, 524-546.
    1. von Tappeiner, H. and A. Jodlbauer (1904) Über die Wirkung der photodynamischen (fluorescierenden) Stoffe auf Protozoen und Enzyme. Dtsch. Arch. Klin. Med. 39, 427-487.
    1. Moan, J. and Q. Peng (2003) An outline of the hundred-year history of PDT. Anticancer Res. 23, 3591-3600.
    1. Krasnovsky, A. A., Jr. (2007) Photodynamic Therapy at the Cellular Level. In Singlet oxygen and primary mechanisms of photodynamic therapy and photodynamic diseases (Edited by A. B. Uzdensky). Research Signpost, Kerala, India.
    1. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng (1998) Photodynamic therapy. J. Natl. Cancer Inst. 90, 889-905.

Publication types

MeSH terms

LinkOut - more resources